The Identification of Novel Prognostic Markers in Melanoma
NCT01002560 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2009-10-27
Summary
The purpose of this project is to analyze tumour tissue from a group of subjects with malignant melanoma, who have been treated at the Royal Marsden Hospital.
Conditions
- Malignant Melanoma
Sponsors & Collaborators
-
Royal Marsden NHS Foundation Trust
lead OTHER
Principal Investigators
-
Professor Martin Gore · Royal Marsden NHS Foundation Trust
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-12-31
- Primary Completion
- 2009-12-31
- Completion
- 2009-12-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy
NCT00897481 ·Status: UNKNOWN
-
Metabolic Phenotypes in Melanoma
NCT05570227 ·Status: RECRUITING ·Phase: NA
-
Stratification of Cutaneous Squamous Cell Carcinomas According to Its Transcriptomic, Metabolic and Inflammatory Characteristics
NCT06476964 ·Status: RECRUITING ·Phase: NA
-
Detection of Melanoma Markers in Lymph Nodes or Peripheral Blood of Patients With Melanoma
NCT00004153 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in Predicting Response to Chemotherapy in Patients With Advanced or Metastatic Melanoma Previously Treated With Carboplatin and Paclitaxel With or Without Sorafenib Tosylate
NCT01209299 ·Status: COMPLETED
-
Skin Tumor Biomarkers by Mass Spectrometry Imaging
NCT06227416 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Melanoma: Genomic Profiles, Molecular Markers and Therapeutic Implications
NCT05119829 ·Status: UNKNOWN
-
Collection of Cerebrospinal Fluid and Tumor Tissue in Subjects With Metastatic Melanoma and Controls
NCT01312506 ·Status: WITHDRAWN
-
Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma
NCT00685750 ·Status: TERMINATED ·Phase: NA
-
A Study to Explore Biomarkers in Samples of Blood, Urine, Stools, Hair Follicles and Saliva From Patients With Cancer
NCT05574738 ·Status: RECRUITING
-
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
NCT06608511 ·Status: RECRUITING
-
Fast Track Diagnosis of Skin Cancer by Advanced Imaging Technologies and Tumour Tapestripping
NCT05389085 ·Status: COMPLETED ·Phase: NA
-
Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With Melanoma
NCT00588198 ·Status: COMPLETED
-
Biopsies of Cancer Patients for Tumor Molecular Characterization
NCT01061944 ·Status: COMPLETED
-
Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer
NCT00283530 ·Status: TERMINATED
-
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma
NCT03727087 ·Status: TERMINATED
-
The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease.
NCT06765850 ·Status: RECRUITING
-
Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment
NCT06851975 ·Status: RECRUITING ·Phase: NA
-
S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma
NCT00898183 ·Status: COMPLETED
-
A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma
NCT04567706 ·Status: RECRUITING
-
Analysis of Expression of Specific Markers in Hepatocellular Carcinoma
NCT00858000 ·Status: COMPLETED
-
Biomarker Differences in Samples From Patients With Undifferentiated Sarcomas
NCT01802125 ·Status: COMPLETED
-
Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer
NCT03214991 ·Status: UNKNOWN
-
Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma
NCT06863870 ·Status: ACTIVE_NOT_RECRUITING
-
Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma
NCT00049010 ·Status: COMPLETED ·Phase: NA